Help
RSS
API
Feed
Maltego
Contact
Domain > www.tecentriq.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2018-08-24
13.56.26.196
(
ClassC
)
2019-09-22
52.9.196.166
(
ClassC
)
2020-04-20
52.52.188.226
(
ClassC
)
2021-03-10
52.52.89.208
(
ClassC
)
2025-12-11
104.18.10.13
(
ClassC
)
2026-01-27
104.18.11.13
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Thu, 24 Oct 2024 04:55:52 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Thu, 24 Oct 2024 05:55:52 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Thu, 24 Oct 2024 04:55:52 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cf_bmJ !DOCTYPE HTML>html langen-US> head> meta charsetUTF-8/> title>Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, & Advanced Melanoma | TECENTRIQ® (atezolizumab)/title> meta namedescription contentLearn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), & Advanced Melanoma | TECENTRIQ® (atezolizumab)/> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.tecentriq.com//> meta propertyog:site_name contenttecentriq/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentCancer Immunotherapy Treatment for NSCLC, ES-SCLC, HCC, & Advanced Melanoma | TECENTRIQ® (atezolizumab)/> meta propertyog:description contentLearn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Non-Small Cell Lung Cancer after surgery and chemo, Metastatic Non-Small Cell Lung Cancer (NSCLC), Extensive-Stage Small Cell Lung Cancer (ES-SCLC), Liver cancer (HCC), & Advanced Melanoma | TECENTRIQ® (atezolizumab)/> meta propertyog:url contenthttps://www.tecentriq.com//> meta propertyog:image contenthttps://www.tecentriq.com/content/dam/gene/tecentriq/global/images/tecentriq-logo.genecoreimg.1200.svg/> meta propertyog:image:type contentimage/svg+xml/> meta propertyog:image:width content605/> meta propertyog:image:height content196/> meta propertyog:image:alt contentTECENTRIQ® (atezolizumab) Logo/> meta nametwitter:card contentsummary_large_image/> meta namepub_date content2023-05-02T10:46:23-0700/> link relicon typeimage/x-icon href/content/dam/gene/tecentriq/global/images/favicon.ico/> link relshortcut icon typeimage/x-icon href/content/dam/gene/tecentriq/global/images/favicon.ico/> link hre
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]